Whereas the MHC-I antigen presentation pathway is crucial for the recognition of tumor cells by CD8+ T cells30, PD-L1 is one of the key immune inhibitory ligands expressed by cancer cells31. The gene discussed is CD8A; the disease is neoplasm.